Actively Recruiting
Screening Tool Artificial Intelligence-based for Predicting the Genetic Risk of BREAST Cancer
Led by AstraZeneca · Updated on 2026-05-13
800
Participants Needed
3
Research Sites
50 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
It is a retrospective observational study that will include female patients aged 18 years or older, who were treated between 2017 and 2024, in both public and private institutions, and identified as at high genetic risk by breast specialists and referred to a geneticist. The artificial intelligence-based tool to be used in this study is developed by the startup WeConecta, which will collect data via WhatsApp about the patients' family cancer history with the aim of predicting the genetic risk of developing breast cancer.
CONDITIONS
Official Title
Screening Tool Artificial Intelligence-based for Predicting the Genetic Risk of BREAST Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female patients
- Aged 18 years or older
- Identified as high genetic risk by breast surgeons
- Referred to a geneticist
- Agree to participate in the study
You will not qualify if you...
- Male patients
- Incomplete information in medical records
- Unaware of biological family history
- Do not agree to participate in the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
Research Site
Golania, Goiás, Brazil, 74605-020
Withdrawn
2
Research Site
Porto Alegre, Rio Grande do Sul, Brazil, 90035-001
Actively Recruiting
3
Research Site
Porto Alegre, Rio Grande do Sul, Brazil, 90035-903
Not Yet Recruiting
Research Team
A
AstraZeneca Clinical Study Information Center
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here